# The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL-6, IL-10 and IL-17 Expression

> **NCT05758259** · PHASE4 · UNKNOWN · sponsor: **Indonesia University** · enrollment: 105 (estimated)

## Conditions studied

- Acne Vulgaris
- Vitamin D

## Interventions

- **DRUG:** combination oral and topical vitamin D
- **DRUG:** oral placebo and topical cholecalciferol
- **DRUG:** oral placebo and basic ingredient placebo topical vitamin D

## Key facts

- **NCT ID:** NCT05758259
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-16
- **Primary completion:** 2023-08
- **Final completion:** 2023-10
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05758259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05758259, "The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL-6, IL-10 and IL-17 Expression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05758259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*